![Maria Ekblad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maria Ekblad
Chief Tech/Sci/R&D Officer at
FOLLICUM AB (PUBL)
Profile
Maria Ekblad currently works at Follicum AB, as Director-Research & Development from 2016 and Iconovo AB, as Head-Generics Development from 2023.
Ms. Ekblad also formerly worked at Aptahem AB, as Chief Operating Officer from 2022 to 2023.
Ms. Ekblad received her graduate degree from the University of Lund.
Maria Ekblad active positions
| Companies | Position | Start |
|---|---|---|
| FOLLICUM AB (PUBL) | Chief Tech/Sci/R&D Officer | 01/01/2016 |
| ICONOVO AB | Corporate Officer/Principal | 01/01/2023 |
Former positions of Maria Ekblad
| Companies | Position | End |
|---|---|---|
| APTAHEM AB | Chief Operating Officer | 01/10/2023 |
Training of Maria Ekblad
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
34
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Follicum AB
 Follicum AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for the treatment of hair-loss | Health Technology |
Iconovo AB
 Iconovo AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that manufactures and wholesales powder-based inhalation drugs and devices | Health Technology |
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Engages in the pharmaceutical businesses, which research and develops medicines for treating and preventing diseases caused by blockage of blood vessels, such as deep vein thrombosis, stroke and heart failure | Health Technology |
- Stock Market
- Insiders
- Maria Ekblad
